Unknown

Dataset Information

0

Ziv-aflibercept in metastatic colorectal cancer.


ABSTRACT: The combination of cytotoxic chemotherapy and antiangiogenic agents has become a conventional treatment option for patients with metastatic colorectal cancer. Ziv-aflibercept is a fusion protein which acts as a decoy receptor for vascular endothelial growth factor (VEGF)-A, VEGF-B, and placental growth factor (PlGF); it was approved in combination with 5-fluorouracil, leucovorin, and irinotecan (FOLFIRI) for the treatment of patients with metastatic colorectal cancer that is resistant to or has progressed after an oxaliplatin-containing fluoropyrimidine-based regimen. Herein we review the role of tumor angiogenesis as the rationale for antiangiogenic therapy, the clinical data associated with ziv-aflibercept, and its current role as a treatment option compared to other antiangiogenic agents, such as bevacizumab and regorafenib.

SUBMITTER: Patel A 

PROVIDER: S-EPMC3869833 | biostudies-literature | 2014

REPOSITORIES: biostudies-literature

altmetric image

Publications

Ziv-aflibercept in metastatic colorectal cancer.

Patel Anuj A   Sun Weijing W  

Biologics : targets & therapy 20131216


The combination of cytotoxic chemotherapy and antiangiogenic agents has become a conventional treatment option for patients with metastatic colorectal cancer. Ziv-aflibercept is a fusion protein which acts as a decoy receptor for vascular endothelial growth factor (VEGF)-A, VEGF-B, and placental growth factor (PlGF); it was approved in combination with 5-fluorouracil, leucovorin, and irinotecan (FOLFIRI) for the treatment of patients with metastatic colorectal cancer that is resistant to or has  ...[more]

Similar Datasets

| S-EPMC6426764 | biostudies-literature
| S-EPMC3256978 | biostudies-other
| S-EPMC6824108 | biostudies-literature
| S-EPMC6958749 | biostudies-literature
| S-EPMC3873022 | biostudies-other
| S-EPMC5038569 | biostudies-literature
| S-EPMC7574189 | biostudies-literature
| S-EPMC6763367 | biostudies-literature
| S-EPMC3808572 | biostudies-literature
| S-EPMC4917211 | biostudies-other